Testing effectiveness (Phase 2)Study completedNCT01275105
What this trial is testing
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Who this might be right for
Allergic Conjunctivitis
Eye Therapies, LLC 68